Recent News

• 03.04.2025 - Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
• 03.04.2025 - Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
• 02.25.2025 - Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
• 02.25.2025 - Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
• 02.11.2025 - Microbot Medical Closes $13 Million Registered Direct Offering
• 02.11.2025 - Microbot Medical Closes $13 Million Registered Direct Offering

Recent Filings

• 03.04.2025 - EX-99.1 EX-99.1
• 03.04.2025 - 8-K Current report
• 02.28.2025 - DEF 14A Other definitive proxy statements
• 02.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.25.2025 - EX-99.1 EX-99.1
• 02.25.2025 - 8-K Current report
• 02.21.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.18.2025 - PRE 14A Other preliminary proxy statements
• 02.18.2025 - D Notice of Exempt Offering of Securities
• 02.13.2025 - EFFECT Notice of Effectiveness